» Articles » PMID: 21513517

Familial Hypercholesterolemia: the Lipids or the Genes?

Overview
Publisher Biomed Central
Date 2011 Apr 26
PMID 21513517
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Familial Hypercholesterolemia (FH) is a common cause of premature cardiovascular disease and is often undiagnosed in young people. Although the disease is diagnosed clinically by high LDL cholesterol levels and family history, to date there are no single internationally accepted criteria for the diagnosis of FH. Several genes have been shown to be involved in FH; yet determining the implications of the different mutations on the phenotype remains a hard task. The polygenetic nature of FH is being enhanced by the discovery of new genes that serve as modifiers. Nevertheless, the picture is still unclear and many unknown genes contributing to the phenotype are most likely involved. Because of this evolving polygenetic nature, the diagnosis of FH by genetic testing is hampered by its cost and effectiveness.In this review, we reconsider the clinical versus genetic nomenclature of FH in the literature. After we describe each of the genetic causes of FH, we summarize the known correlation with phenotypic measures so far for each genetic defect. We then discuss studies from different populations on the genetic and clinical diagnoses of FH to draw helpful conclusions on cost-effectiveness and suggestions for diagnosis.

Citing Articles

Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.

Blokhina A, Ershova A, Kiseleva A, Sotnikova E, Zharikova A, Zaicenoka M PLoS One. 2024; 19(12):e0315693.

PMID: 39705280 PMC: 11661581. DOI: 10.1371/journal.pone.0315693.


Clinical applications of polygenic risk score for coronary artery disease through the life course.

Fahed A, Natarajan P Atherosclerosis. 2023; 386:117356.

PMID: 37931336 PMC: 10842813. DOI: 10.1016/j.atherosclerosis.2023.117356.


Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology.

Caffarelli C, Santamaria F, Piro E, Basilicata S, DAntonio L, Tchana B Ital J Pediatr. 2023; 49(1):115.

PMID: 37679850 PMC: 10485969. DOI: 10.1186/s13052-023-01522-8.


Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care.

Kamal A, Kanchau J, Shahuri N, Mohamed-Yassin M, Baharudin N, Abdul Razak S Am J Case Rep. 2023; 24:e939489.

PMID: 37185657 PMC: 10152508. DOI: 10.12659/AJCR.939489.


Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.

Reijman M, Defesche J, Wiegman A Curr Opin Lipidol. 2023; 34(6):287-295.

PMID: 36752612 PMC: 10624405. DOI: 10.1097/MOL.0000000000000863.


References
1.
. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991; 303(6807):893-6. PMC: 1671226. DOI: 10.1136/bmj.303.6807.893. View

2.
Clarke R . Commentary: Lipoprotein(a) and atherosclerosis. Int J Epidemiol. 2011; 40(2):478-9. DOI: 10.1093/ije/dyr015. View

3.
Laurie A, George P . Evaluation of high-resolution melting analysis for screening the LDL receptor gene. Clin Biochem. 2009; 42(6):528-35. DOI: 10.1016/j.clinbiochem.2008.11.015. View

4.
Harada K, Miyamoto Y, Morisaki H, Ohta N, Yamanaka I, Kokubo Y . A novel Thr56Met mutation of the autosomal recessive hypercholesterolemia gene associated with hypercholesterolemia. J Atheroscler Thromb. 2010; 17(2):131-40. DOI: 10.5551/jat.2873. View

5.
Marian A . PCSK9 as a therapeutic target in atherosclerosis. Curr Atheroscler Rep. 2010; 12(3):151-4. DOI: 10.1007/s11883-010-0099-2. View